The Rho Family GEF FARP2 Is Activated by Apkcι to Control Tight
Total Page：16
File Type：pdf, Size：1020Kb
© 2019. Published by The Company of Biologists Ltd | Journal of Cell Science (2019) 132, jcs223743. doi:10.1242/jcs.223743 SHORT REPORT The Rho family GEF FARP2 is activated by aPKCι to control tight junction formation and polarity Ahmed Elbediwy1,¶,**, Yixiao Zhang2,*,**, Mathias Cobbaut2,**, Philippe Riou2,‡, Ray S. Tan2,§, Selene K. Roberts6, Chris Tynan6, Roger George3, Svend Kjaer3, Marisa L. Martin-Fernandez6, Barry J. Thompson1, Neil Q. McDonald4 and Peter J. Parker2,5,‡‡ ABSTRACT requirement for determining asymmetric/polarised cellular The elaboration of polarity is central to organismal development and behaviours (reviewed in Chen and Zhang, 2013; Suzuki and to the maintenance of functional epithelia. Among the controls Ohno, 2006). This was initially established in Caenorhabditis determining polarity are the PAR proteins, PAR6, aPKCι and PAR3, elegans (Tabuse et al., 1998) where the aPKC orthologue, along regulating both known and unknown effectors. Here, we identify with other PAR proteins, have been shown to play critical roles in FARP2 as a ‘RIPR’ motif-dependent partner and substrate of aPKCι cell polarisation; the same conserved modules, aPKC, PAR6 and that is required for efficient polarisation and junction formation. PAR3, were subsequently shown to operate in mammals (note in Binding is conferred by a FERM/FA domain–kinase domain mammals there are several PAR6 and PAR3 family proteins) interaction and detachment promoted by aPKCι-dependent (Joberty et al., 2000). ι phosphorylation. FARP2 is shown to promote GTP loading of The direct interaction of aPKC with regulatory proteins and Cdc42, which is consistent with it being involved in upstream substrates is a particular feature of its action. In C. elegans there is a ι regulation of the polarising PAR6–aPKCι complex. However, we dynamic cycling between highly localised PAR3-containing aPKC show that aPKCι acts to promote the localised activity of FARP2 complexes (inactive) and dispersed Cdc42 containing complexes through phosphorylation. We conclude that this aPKCι−FARP2 (active) (Rodriguez et al., 2017); the inactivity being determined by complex formation acts as a positive feedback control to drive interaction of the CR3 region of PAR3 with the substrate-binding ι ι polarisation through aPKCι and other Cdc42 effectors. pocket of aPKC (Soriano et al., 2016). Mutation of the aPKC RIPR partner interaction motif, as seen rarely but repeatedly in cancers, This article has an associated First Person interview with the first leads to a failure of the mutant protein to support normal polarisation ι author of the paper. (Linch et al., 2013). In pathophysiological states, aPKC hyperactivation through Ras-dependent mechanisms can also drive KEY WORDS: Cdc42, FARP, Atypical protein kinase C, Polarity a loss of polarity (Linch et al., 2014); such aPKC hyperactivation has been reported to overcome contact inhibition through Hippo/Yap INTRODUCTION signalling (Archibald et al., 2015). This suppression of polarity- Atypical protein kinase Cs (PKC), aPKCζ and aPKCι, are serine/ dependent growth inhibition is consistent with a role in tumorigenesis threonine specific protein kinases that form a distinctive subset of as seen in an inducible lung model of Ras-dependent tumour PKC proteins with characteristic regulatory inputs, outputs and formation (Regala et al., 2009). pharmacology (for a review, see Parker et al., 2014). The most FERM, RhoGEF and pleckstrin domain-containing proteins well-characterised physiological role relates to aPKCι and its (FARPs) are guanine nucleotide exchange factors (GEFs) for Rho family proteins (Kubo et al., 2002; Ni et al., 2003; Toyofuku et al., 2005), and FARP2 is identified here as a protein partner in an aPKCι 1Epithelial Biology Laboratory, Francis Crick Institute, 1 Midland Road, London NE1 1AT, UK. 2Protein Phosphorylation Laboratory, Francis Crick Institute, 1 Midland interactome screen. FARP2 is shown to act as a GEF for the Road, London NE1 1AT, UK. 3Structural Biology Team, Francis Crick Institute, 1 upstream polarity regulator Cdc42 (Noda et al., 2001); however, we 4 Midland Road, London NE1 1AT, UK. Signalling and Structural Biology Laboratory, demonstrate that FARP2 also acts downstream of aPKCι, where it Francis Crick Institute, 1 Midland Road, London NE1 1AT, UK. 5School of Cancer and Pharmaceutical Sciences, King’s College London, Guy’s Campus, London controls polarity. The aPKCι–FARP2 module thus comprises a SE1 1UL, UK. 6Central Laser Facility, STFC Rutherford Appleton Laboratory, novel positive feedback control acting to regulate polarity through Harwell Oxford, Didcot, Oxford OX11 0QX, UK. *Present address: 2121 Berkeley Way, University of California, Berkeley, CA 94702, its own assembly and turnover. USA. ‡Present address: Novintum Bioscience, London Bioscience Innovation Centre, 2 Royal College Street, London NW1 0NH, UK. §Present address: Guy’s and RESULTS AND DISCUSSION ¶ St Thomas’ NHS Foundation Trust, London, SE1 9RT, UK. Present address: ι Kingston University London, School of Life Science, Penrhyn Road, London, aPKC interacts with and phosphorylates FARP proteins KT1 2EE, UK. A proteomics screen for endogenously expressed proteins associating **These authors contributed equally to this work with aPKCι in HCT116 cells revealed that FARP2 is an aPKCι ι ‡‡Author for correspondence ([email protected]) interactor (Fig. S1A). We validated the interaction of aPKC with FARPs by co-expression with aPKCι and immunoprecipitation M.C., 0000-0003-0279-0336; R.S.T., 0000-0001-6338-1080; P.J.P., 0000-0002- (antisera to the endogenous protein was not effective for native 6218-2933 aPKCι recovery). aPKCι efficiently binds to both FARP1 and FARP2 This is an Open Access article distributed under the terms of the Creative Commons Attribution (Fig. 1A,B). Complex formation with FARP2 was corroborated License (https://creativecommons.org/licenses/by/4.0), which permits unrestricted use, – distribution and reproduction in any medium provided that the original work is properly attributed. in cells employing a fluorescence resonance energy transfer fluorescence-lifetime imaging microscopy (FRET-FLIM)-based Received 9 August 2018; Accepted 28 February 2019 approach (Fig. S1B). Co-expression with aPKCι revealed an Journal of Cell Science 1 SHORT REPORT Journal of Cell Science (2019) 132, jcs223743. doi:10.1242/jcs.223743 Fig. 1. See next page for legend. Journal of Cell Science 2 SHORT REPORT Journal of Cell Science (2019) 132, jcs223743. doi:10.1242/jcs.223743 Fig. 1. FARP2 is a RIPR-dependent substrate of aPKCι that is responsible FARP2 is required for efficient initiation of junction formation for maintaining tight junctions and polarity. (A,B) FARP1 and FARP2 To assess whether FARP2 also had a role in junctional initiation, co-precipitate with aPKC. HCT116 cells were co-transfected with plasmids cells were subjected to a Ca2+ switch (Elbediwy et al., 2012). expressing FLAG-tagged FARP1 (A) or FARP2 (B) and GFP, GFP-tagged aPKCι or GFP-tagged aPKCι containing a RIPR to AIPA mutation (R480A/ Depletion of FARP2 prevented proper junctional establishment, as R483A). Immunoprecipitates were analysed with the indicated antibodies. evident through the disorder of the marker ZO-1; this was seen 2+ Images are of representative blots of n=3. (C) GFP–PKCι phosphorylates prominently at 8 h post Ca re-addition, phenocopying the effects FARP1 and FARP2 in cells. HCT116 cells were co-transfected with plasmids of aPKCι and Cdc42 knockdown (Fig. 2A). Following depletion of expressing FLAG-tagged FARP1 or FARP2, and GFP or GFP-tagged aPKCι. FARP2 with a validated siRNA, we found that the TER was Immunoprecipitates (IP) were analysed via ProQ diamond staining or with the significantly reduced (∼40%), which is a similar level of reduction indicated antibodies. (D) FARP2 and not FARP1 is involved in junctional ι establishment after Ca2+ switch. Caco-2 cells were subjected to siRNA to what is seen upon aPKC or Cdc42 depletion (Fig. 2B). These treatment (p represents the use of ON-TARGETplus SMARTpool siRNA, effects were also observed with a second FARP2 siRNA (Fig. S3A). Dharmacon), processed for Ca2+ switch immunofluorescence and stained for To assess the penetrance of this dependence on FARP2 for the junctional marker ZO-1. A representative example of n=3 experiments with de novo junction formation, we employed A431 cells. When these six coverslips per immunofluorescence experiment is shown. (E) FARP1 cells are serum-starved, ZO-1 is lost from cell–cell contacts and 2+ depletion has no effect on junctional permeability as indicated by a Ca switch upon addition of EGF, ZO-1 relocalises in a time-dependent TER assay. A representative example of n=3 experiments is shown. (F) FARP2 fashion as tight junctions (TJs) re-form (Van Itallie et al., 1995). We depletion has a substantial effect on junctional permeability as indicated by a Ca2+ switch transepithelial assay. A representative example of n=3 depleted FARP2 and assessed ZO-1 localisation at time 0 and experiments with six samples per experiment is shown. (G) 3D lumen formation 30 min post EGF addition. We found that the normal coherent in a CaCo2 model is disturbed upon knockdown of either FARP2, Cdc42 or localisation of ZO-1 became severely fragmented upon depletion PKCι. CaCo2 cells were grown on a Matrigel-coated surface as described in the of FARP2, further validating a role for FARP2 in junction Materials and Methods. Cysts were stained for ZO-1 (green), F-actin (red) as establishment (Fig. 2C). By using individual siRNAs directed at ’ indicated and Hoechst 33342 (stained according to manufacturer s FARP2 in Caco-2 cells, we also observed a disruption of ZO-1 instructions; Sigma-Aldrich) (blue). (H) Quantification of the proportion of single lumen cysts for experiments as in G. n≥100 cysts were counted per experiment. localisation (Fig. S3B) and a drop in TER, albeit to a lesser extent Results are mean±s.d. ns, not significant (P>0.05); ***P≤0.001; ****P≤0.0001 than observed in the establishment assay (Fig. S3C). This indicates (unpaired t-test). siCtrl, control siRNA.